These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 38162075

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Clinical significance of intrarenal vascular lesions in non-hypertensive patients with IgA nephropathy.
    Huang Z, Hu Y, Chen B, Liang Y, Li D, Qiu W, Zhang J, Chen C.
    J Nephrol; 2023 Mar; 36(2):429-440. PubMed ID: 36538201
    [Abstract] [Full Text] [Related]

  • 24. Dividing CKD stage 3 into G3a and G3b could better predict the prognosis of IgA nephropathy.
    Zhang JJ, Yu GZ, Zheng ZH, Liu YF, Du YY, Quan SX, Liu YJ, Lv JC, Zhang H.
    PLoS One; 2017 Mar; 12(4):e0175828. PubMed ID: 28414748
    [Abstract] [Full Text] [Related]

  • 25. High Neutrophil-To-Lymphocyte Ratio Is an Independent Risk Factor for End Stage Renal Diseases in IgA Nephropathy.
    Wang S, Dong L, Pei G, Jiang Z, Qin A, Tan J, Tang Y, Qin W.
    Front Immunol; 2021 Mar; 12():700224. PubMed ID: 34456912
    [Abstract] [Full Text] [Related]

  • 26. Uric acid-based ratios for predicting renal failure in Chinese IgA nephropathy patients.
    Qin A, Yang D, Wang S, Dong L, Tan J, Tang Y, Qin W.
    Int J Med Sci; 2023 Mar; 20(12):1584-1591. PubMed ID: 37859692
    [Abstract] [Full Text] [Related]

  • 27. Glomerular C4 deposition and glomerulosclerosis predict worse renal outcomes in Chinese patients with IgA nephropathy.
    Yang Y, Tang X, Yang Y, Li X, Li L, Huang K, Li Y, Li J, Fu P.
    Ren Fail; 2020 Nov; 42(1):629-637. PubMed ID: 32660366
    [Abstract] [Full Text] [Related]

  • 28. The predictive value of free thyroxine combined with tubular atrophy/interstitial fibrosis for poor prognosis in patients with IgA nephropathy.
    Yang B, Zhou W, Cui L, Tian L, Ni Y, Yang M, Yang Y.
    Front Endocrinol (Lausanne); 2024 Nov; 15():1372824. PubMed ID: 38808109
    [Abstract] [Full Text] [Related]

  • 29. Hyperuricemia and Progression of CKD in Children and Adolescents: The Chronic Kidney Disease in Children (CKiD) Cohort Study.
    Rodenbach KE, Schneider MF, Furth SL, Moxey-Mims MM, Mitsnefes MM, Weaver DJ, Warady BA, Schwartz GJ.
    Am J Kidney Dis; 2015 Dec; 66(6):984-92. PubMed ID: 26209544
    [Abstract] [Full Text] [Related]

  • 30. [Effect of serum IgA/C3 and glomerular C3 staining on clinical prognosis in patients with IgA nephropathy].
    Pei GQ, Qin AY, Wang SQ, Tan L, Tang Y, Qin W.
    Zhonghua Yi Xue Za Zhi; 2020 Aug 11; 100(30):2372-2377. PubMed ID: 32791814
    [Abstract] [Full Text] [Related]

  • 31. Factors influencing the occurrence of hyperuricemia and poor cardiac and renal outcomes in chronic kidney disease.
    Liu WW, Yang GB, Liu ZY, Guo Y, Duan LX, Yuan JH, Liao L, Zhang CF, Lu JR, Hu J, Chen J.
    Eur Rev Med Pharmacol Sci; 2024 Jan 11; 28(1):342-349. PubMed ID: 38235885
    [Abstract] [Full Text] [Related]

  • 32. Renal Megalin mRNA Downregulation Is Associated with CKD Progression in IgA Nephropathy.
    Wen L, Wang X, Ji F, Wen J, Zhao Z.
    Am J Nephrol; 2022 Jan 11; 53(6):481-489. PubMed ID: 35661648
    [Abstract] [Full Text] [Related]

  • 33. Long-term outcome of IgA nephropathy with minimal change disease: a comparison between patients with and without minimal change disease.
    Li XW, Liang SS, Le WB, Cheng SQ, Zeng CH, Wang JQ, Liu ZH.
    J Nephrol; 2016 Aug 11; 29(4):567-73. PubMed ID: 26537358
    [Abstract] [Full Text] [Related]

  • 34. Arteriolar hyalinosis and renal outcomes in patients with immunoglobulin A nephropathy.
    Shen Y, Xiao T, Yu Z, Huang Y, He T, Li H, Zhang J, Xiong J, Zhao J.
    Ren Fail; 2022 Dec 11; 44(1):994-1003. PubMed ID: 35658824
    [Abstract] [Full Text] [Related]

  • 35. Long-term renal survival and undetected risk factors of IgA nephropathy in Chinese children-a retrospective 1243 cases analysis from single centre experience.
    Wu H, Fang X, Xia Z, Gao C, Peng Y, Li X, Zhang P, Kuang Q, Wang R, Wang M.
    J Nephrol; 2020 Dec 11; 33(6):1263-1273. PubMed ID: 32507961
    [Abstract] [Full Text] [Related]

  • 36. The effect of fibrinoid necrosis on the clinical features and outcomes of primary IgA nephropathy.
    Chen H, Liu Y, Wei L, Wang H, Zheng Z, Yan T, Jia J, Li D.
    BMC Nephrol; 2023 Dec 11; 24(1):366. PubMed ID: 38082385
    [Abstract] [Full Text] [Related]

  • 37. Lower serum bilirubin is associated with poor renal outcome in IgA nephropathy patients.
    Jiang Z, Tan J, Wang S, Dong L, Han X, Tang Y, Qin W.
    Int J Med Sci; 2021 Dec 11; 18(13):2964-2970. PubMed ID: 34220324
    [Abstract] [Full Text] [Related]

  • 38. Plasma neutrophil gelatinase-associated lipocalin as a potential predictor of adverse renal outcomes in immunoglobulin A nephropathy.
    Park GY, Yu CH, Kim JS, Kang YJ, Kwon O, Choi JY, Cho JH, Kim CD, Kim YL, Park SH.
    Korean J Intern Med; 2015 May 11; 30(3):345-53. PubMed ID: 25995665
    [Abstract] [Full Text] [Related]

  • 39. Uric Acid and the Risks of Kidney Failure and Death in Individuals With CKD.
    Srivastava A, Kaze AD, McMullan CJ, Isakova T, Waikar SS.
    Am J Kidney Dis; 2018 Mar 11; 71(3):362-370. PubMed ID: 29132945
    [Abstract] [Full Text] [Related]

  • 40. Clinicopathologic features of IgA nephropathy patients with different levels of proteinuria.
    Ai Z, Xu R, Liu W, Zhou Q, Li B, Huang F, Yu X, Yang Q.
    Clin Nephrol; 2016 Jul 11; 86(7):35-41. PubMed ID: 27251340
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.